Skip to content

SIGA Technologies SIGA Enterprise value

Enterprise value at other companies

Emergent Biosolutions logo
Emergent BiosolutionsEBS
$851.75M+8.6%
Opko Health logo
Opko HealthOPK
$918.12M-21.5%
Merck & Co. logo
Merck & Co.MRK
$341.11B+34.2%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$1.77B+1,855%
Septerna, Inc. logo
Septerna, Inc.SEPN
$1.03B+1,325%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
$5.84B+181%

Other financials

Income statement

See full
Revenue$6.2M-11.3%
Gross profit$3.3M-52.0%
Operating income-$5.3M-136%
Net income-$3.5M-746%
EPS (diluted)-$0.05-400%

Balance sheet

See full
Cash & equivalents$145.6M-10.3%
Total debt$601.0K-50.6%
Total equity$151.6M-29.8%
Total assets$219.4M-11.2%

Cash flow

See full
Operating cash flow-$8.7M-223%
CapEx--100%
Free cash flow-$8.7M-223%

Valuation

See full
Market cap$261.08M-44.3%
P/E10.3×+3.8×
P/S2.8×+0.2×

Profitability

See full
Gross margin65.4%-11.2pp
Operating margin52.4%-7.8pp
Net margin43.2%-6.1pp
FCF margin66.2%

Returns & leverage

See full
Return on equity39.9%-18.5pp
Debt / equity0.0×
Current ratio3.2×-5.2×

Where this comes from

Calculated from SIGA Technologies’s reported figures.

The official record: SIGA Technologies’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about SIGA Technologies's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SIGA Technologies's enterprise value?
SIGA Technologies (SIGA) reported enterprise value of $238.34M in Q1 2026.
How has SIGA Technologies's enterprise value changed year-over-year?
SIGA Technologies's enterprise value increased by 3.4% year-over-year, from $230.42M to $238.34M.
What is the long-term trend for SIGA Technologies's enterprise value?
Over 2 years (2023 to 2025), SIGA Technologies's enterprise value has grown at a 6.8% compound annual growth rate (CAGR), from $248.53M to $283.34M.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.